AI
PRLB icon

ArchPoint Investors’s Protolabs PRLB Stock Holding History

ArchPoint Investors’s Portfolio PRLB Stock Details PRLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,776
Closed -$2.16M – 97
2021
Q1 		$2.16M Buy
+17,776
New +$2.96M 0.61% 28

Other funds holding PRLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

ArchPoint Investors's PRLB Position: Q2 2021 in Review

ArchPoint Investors sold out of Protolabs (PRLB) in Q2 2021, closing a stake of 17,776 shares — an estimated $2.16M sold.

ArchPoint Investors first reported a position in PRLB in Q1 2021 and held it in 1 quarter. The position peaked at $2.16M in Q1 2021. 273 funds tracked by Wall St. Rank hold PRLB as of Q2 2021.

  • ArchPoint Investors reported no remaining Protolabs position as of Q2 2021 after selling out during the quarter.
  • ArchPoint Investors sold 17,776 Protolabs shares in Q2 2021, an estimated $2.16M.
  • ArchPoint Investors first reported a position in Protolabs in Q1 2021 and held it in 1 quarter.
  • ArchPoint Investors's Protolabs position peaked at $2.16M in Q1 2021.
  • 273 funds tracked by Wall St. Rank held Protolabs as of Q2 2021.

Based on ArchPoint Investors's 13F filing for Q2 2021, filed 13 Aug 2021.